BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24603587)

  • 1. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
    Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
    Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
    Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
    Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
    Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
    Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
    Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
    Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
    van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
    Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare expression of T-cell markers in classical Hodgkin's lymphoma.
    Tzankov A; Bourgau C; Kaiser A; Zimpfer A; Maurer R; Pileri SA; Went P; Dirnhofer S
    Mod Pathol; 2005 Dec; 18(12):1542-9. PubMed ID: 16056244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
    Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
    N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas.
    Bai M; Papoudou-Bai A; Horianopoulos N; Grepi C; Agnantis NJ; Kanavaros P
    Hum Pathol; 2007 Jan; 38(1):103-13. PubMed ID: 16949642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
    Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
    Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
    Smolewski P; Niewiadomska H; Los E; Robak T
    Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phase.
    Tiemann M; Claviez A; Lüders H; Zimmermann M; Schellong G; Dörffel W; Parwaresch R
    Mod Pathol; 2005 Nov; 18(11):1440-7. PubMed ID: 16056247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma.
    Kim LH; Nadarajah VS; Peh SC; Poppema S
    Histopathology; 2004 Mar; 44(3):257-67. PubMed ID: 14987230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
    Koh YW; Jeon YK; Yoon DH; Suh C; Huh J
    Tumour Biol; 2016 Jun; 37(6):7507-14. PubMed ID: 26678894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications.
    Martín P; Salas C; Provencio M; Abraira V; Bellas C
    Leuk Lymphoma; 2011 Nov; 52(11):2162-8. PubMed ID: 21749309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
    Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Viviani S; Bonfante V; Nadali G; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McDonnell TJ; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Blood; 2002 Dec; 100(12):3935-41. PubMed ID: 12433696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.